Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$53.58 - $57.02 $63,331 - $67,397
-1,182 Reduced 13.86%
7,348 $414,000
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $8,512 - $11,964
200 Added 2.4%
8,530 $482,000
Q4 2023

Feb 15, 2024

SELL
$32.18 - $46.57 $35,848 - $51,878
-1,114 Reduced 11.8%
8,330 $375,000
Q2 2023

Jul 25, 2023

BUY
$31.86 - $67.26 $300,885 - $635,203
9,444 New
9,444 $409,000
Q2 2022

Aug 01, 2022

BUY
$87.2 - $114.05 $1,308 - $1,710
15 Added 0.22%
6,974 $748,000
Q4 2020

Feb 09, 2021

BUY
$85.88 - $105.36 $597,638 - $733,200
6,959 New
6,959 $724,000
Q2 2020

Jul 29, 2020

SELL
$48.02 - $79.04 $1.7 Million - $2.79 Million
-35,317 Closed
0 $0
Q1 2020

Apr 30, 2020

BUY
$36.95 - $62.95 $148,169 - $252,429
4,010 Added 12.81%
35,317 $1.84 Million
Q4 2019

Jan 29, 2020

SELL
$47.06 - $56.64 $1.45 Million - $1.74 Million
-30,706 Reduced 49.52%
31,307 $1.76 Million
Q2 2019

Aug 19, 2019

BUY
$39.26 - $54.21 $2.43 Million - $3.36 Million
62,013 New
62,013 $3.36 Million
Q1 2019

Apr 11, 2019

SELL
$29.84 - $43.92 $1.41 Million - $2.08 Million
-47,377 Closed
0 $0
Q4 2018

Feb 01, 2019

SELL
$29.95 - $46.34 $748,690 - $1.16 Million
-24,998 Reduced 34.54%
47,377 $1.48 Million
Q3 2018

Nov 08, 2018

SELL
$40.12 - $45.55 $1.09 Million - $1.23 Million
-27,101 Reduced 27.24%
72,375 $3.3 Million
Q2 2018

Aug 09, 2018

BUY
$38.72 - $42.52 $3.85 Million - $4.23 Million
99,476 New
99,476 $4.17 Million
Q1 2018

May 08, 2018

SELL
$39.4 - $47.39 $4.4 Million - $5.3 Million
-111,780 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$39.4 - $47.39 $4.4 Million - $5.3 Million
111,780 New
111,780 $4.59 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.